🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase II clinical trial studies how well treosulfan, thiotepa, fludara...
Status
Recruiting
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2021-05-05
Trial ID
NCT03980769
The study hypothesis is that nutritional supplementation together with bisp...
Status
Completed
Location
Department of Geriatric Medicine R94, Karolinska University Hospital
Start Date
2004-12
Trial ID
NCT01950169
Treatments Being Tested
This is a research study involving the treatment of patients with hematolog...
Status
Terminated
Location
Thomas Jefferson University
Start Date
2011-04
Trial ID
NCT01350258
RATIONALE: Bortezomib and thalidomide may stop the growth of multiple myelo...
Status
Completed
Location
City of Hope Medical Center
Start Date
2008-01-16
Trial ID
NCT00792142
This phase II trial studies the effects of luspatercept with or without hyd...
Status
Terminated
Location
Mayo Clinic Hospital in Arizona
Start Date
2023-02-20
Trial ID
NCT05005182
This phase III trial studies whether adding apalutamide to the usual treatm...
Status
Active Not Recruiting
Location
Cancer Center at Saint Joseph's
Start Date
2020-04-16
Trial ID
NCT04134260
Anti-rejection medicines, also known as immunosuppressive drugs, are prescr...
Status
Completed
Location
Duke University Health System
Start Date
2018-07-30
Trial ID
NCT03504241
The study will include newly-diagnosed AML patients, not suffering acute pr...
Status
Unknown
Location
Weill Cornell Medicine
Start Date
2017-07-03
Trial ID
NCT03257241
Treatments Being Tested
This phase II trial studies how well combination chemotherapy works in trea...
Status
Recruiting
Location
Children's Hospital of Alabama
Start Date
2020-10-19
Trial ID
NCT04322318
Treatments Being Tested
This phase II trial tests how well venetoclax with cladribine and cytarabin...
Status
Recruiting
Location
University of Miami Miller School of Medicine-Sylvester Cancer Center
Start Date
2025-01-03
Trial ID
NCT06504459